ADVANCED PROSTATE CANCER
Clinical trials for ADVANCED PROSTATE CANCER explained in plain language.
Never miss a new study
Get alerted when new ADVANCED PROSTATE CANCER trials appear
Sign up with your email to follow new studies for ADVANCED PROSTATE CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Scientists test 'Adaptive' strategy to outsmart advanced prostate cancer
Disease control OngoingThis early-stage study is testing a personalized, 'adaptive' treatment approach for men with advanced prostate cancer that has spread but still responds to hormone-blocking therapy. The goal is to see if adjusting the timing and dose of standard hormone therapy based on a patient…
Matched conditions: ADVANCED PROSTATE CANCER
Phase: EARLY_PHASE1 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated Mar 19, 2026 14:56 UTC
-
Shorter radiation course tested for aggressive prostate cancer
Disease control OngoingThis study compares two different radiation treatment schedules for men with high-risk prostate cancer that hasn't spread. All participants receive hormone therapy plus radiation, but one group gets 5 weekly treatments while the other gets 38 daily treatments. The main goal is to…
Matched conditions: ADVANCED PROSTATE CANCER
Phase: PHASE2 • Sponsor: CCTU • Aim: Disease control
Last updated Mar 17, 2026 13:09 UTC
-
Can men 'Comeback' from prostate cancer treatment? trial tests hormone recovery
Disease control OngoingThis study is testing a two-drug combination (relugolix and darolutamide) for men with hormone-sensitive prostate cancer. The main goal is to see if men's testosterone levels return to normal within 18 months after finishing the two-year treatment. Researchers will also closely m…
Matched conditions: ADVANCED PROSTATE CANCER
Phase: PHASE2 • Sponsor: Atish Choudhury, MD • Aim: Disease control
Last updated Mar 13, 2026 15:05 UTC